Head-to-head · Cost-Efficiency Index
Zeuss vs NativeMed
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Zeuss
Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription.
Visit ZeussNativeMed
Cost-first shoppers who want a flat monthly rate regardless of dose, without a separate membership fee.
Visit NativeMedThe verdict
Zeuss and NativeMed tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers. For most shoppers we'd start with Zeuss (ranked #186, a hair above #187) — Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription. But NativeMed is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Zeuss.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Zeuss | NativeMed |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $125/mo (starting dose, compounded) | $149/mo (all doses, 3-month plan, compounded) |
| Tirzepatide / mo | $175/mo (starting dose, compounded) | $183/mo (all doses, 3-month plan, compounded) |
| Semaglutide / yr (modeled) | $1,500 | $1,788 |
| Tirzepatide / yr (modeled) | $2,100 | $2,196 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #186 | #187 |
Zeuss
63/100Where the value is
- Genuinely no-subscription billing confirmed in its own FAQ ('no recurring charges or automatic refills') — patients pay per order, not a locked recurring plan
- LegitScript certified, with the badge and verification link displayed on the homepage
- States it 'partners exclusively with 503A and 503B state-licensed compounding pharmacies'
The tradeoffs
- Both $125 and $175 are 'starting at' prices with no disclosed dose (mg) or confirmation the price holds at higher/titrated doses
- No compounding pharmacy is named, only 'licensed partner pharmacy'
Regulatory note: the FDA issued a warning letter to Zeuss LLC dba Zeuss in February 2026. We still list and link to Zeuss; you should know the letter is on the public record before you decide.
NativeMed
63/100Where the value is
- Flat 'same price any dose' pricing removes the dose-tier price-creep common at other compounded GLP-1 sites
- No stated membership/platform fee stacked on top of the medication price
- Free 48-hour shipping advertised on the homepage
The tradeoffs
- The site's own '3-month starter' pricing table implies the real first-month charge ($179-$259) runs higher than the advertised $149-$183/mo headline rate
- No published list of which U.S. states NativeMed actually serves — a buyer can't confirm eligibility before starting the intake
Regulatory note: the FDA issued a warning letter to NativeMed LLC dba NativeMed in June 2026. We still list and link to NativeMed; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.